LifeMD, Inc. (NASDAQ:LFMD) Stock Has Average Price Target of $7.57 According to Analysts

Shares of LifeMD, Inc. (NASDAQ:LFMD) have received an average recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $7.57.

LFMD has been the subject of a number of research reports. KeyCorp set a $5.00 target price on shares of LifeMD and gave the company an “overweight” rating in a report on Friday, August 7th. BTIG Research dropped their price target on shares of LifeMD from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Thursday, August 6th. Zacks Research raised shares of LifeMD from a “strong sell” rating to a “hold” rating in a research report on Monday, August 17th. Wall Street Zen lowered LifeMD from a “hold” rating to a “sell” rating in a research note on Saturday, July 18th. Finally, B. Riley Financial began coverage on LifeMD in a research note on Friday, September 11th. They issued a “buy” rating and a $8.00 price objective for the company.

Institutional Trading of LifeMD

Several hedge funds have recently bought and sold shares of LFMD. Integrated Wealth Concepts LLC bought a new position in shares of LifeMD in the second quarter worth about $25,000. Chapin Davis Inc. bought a new position in shares of LifeMD during the 3rd quarter valued at approximately $29,000. R Squared Ltd purchased a new stake in LifeMD in the 1st quarter worth approximately $41,000. Corient Private Wealth LP purchased a new stake in LifeMD in the 2nd quarter worth approximately $63,000. Finally, Quantbot Technologies LP purchased a new stake in LifeMD in the 2nd quarter worth approximately $89,000. Institutional investors own 35.52% of the company’s stock.

LifeMD Price Performance

NASDAQ LFMD opened at $2.19 on Wednesday. The stock has a market capitalization of $105.80 million, a price-to-earnings ratio of -43.89 and a beta of 2.19. LifeMD has a 1-year low of $2.06 and a 1-year high of $5.73. The business’s fifty day moving average price is $2.78 and its 200-day moving average price is $3.64.

LifeMD (NASDAQ:LFMD) last issued its quarterly earnings data on Wednesday, August 5th. The company reported ($0.16) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.01). The firm had revenue of $47.28 million during the quarter, compared to the consensus estimate of $49.16 million. LifeMD had a negative return on equity of 168.23% and a net margin of 0.10%. Equities research analysts anticipate that LifeMD will post -0.48 EPS for the current year.

LifeMD Company Profile

LifeMD, Inc is a direct-to-consumer telehealth company that provides virtual medical care, prescription treatments and related health services through its digital platform. The company connects patients with licensed health care providers for online consultations, ongoing care and, when clinically appropriate, prescription medications.

Its services include virtual primary care and programs focused on areas such as weight management, men’s health, women’s health, dermatology and chronic-care support.